![Hendrik-Tobias Arkenau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hendrik-Tobias Arkenau
Fundador en Sarah Cannon Research Institute UK Ltd. .
Cargos activos de Hendrik-Tobias Arkenau
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Sarah Cannon Research Institute UK Ltd.
![]() Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Director Técnico/Científico/I+D | 01/01/1993 | - |
Fundador | 01/01/1993 | - |
Historial de carrera de Hendrik-Tobias Arkenau
Estadísticas
Internacional
Reino Unido | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorial
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Sarah Cannon Research Institute UK Ltd.
![]() Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Commercial Services |